Prophylactic TCM for Mitigation of EGFR-TKI Related Dermatological Adverse Effect

Clinical trial NCT05204758 · COMPLETED

Trial details

NCT number: NCT05204758
Sponsor: China Medical University Hospital
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Advanced Lung Adenocarcinoma

Start date: 2016-05-12
Primary completion: 2017-12-31
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.